Reach Us +44-7480-724769

Journal of Nanomaterials & Molecular NanotechnologyISSN: 2324-8777

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, J Nanomater Mol Nanotechnol Vol: 2 Issue: 4

Neuroprotective Effect of Photoactive Quantum Dots in Progressive Retinal Photoreceptor Degeneration

Jeffrey L Olson1*, Raul Velez-Montoya1, Naresh Mandava1 and Conrad R Stoldt2
1Department of Ophthalmology, University of Colorado Health and Science Center, Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, CO, USA
2Department of Mechanical Engineering, University of Colorado Boulder, Boulder CO, USA
Corresponding author : Jeffrey L Olson, MD
Department of Ophthalmology, University of Colorado School of Medicine, 1675 Aurora Court, Aurora CO 80045, USA
Tel: (720) 848.2500; Fax: (720) 848.5014
E-mail: [email protected]
Received: March 16, 2013 Accepted: July 24, 2013 Published: July 31, 2013
Citation: Olson JL, Velez-Montoya R, Mandava N, Stoldt CR (2013) Neuroprotective Effect of Photoactive Quantum Dots in Progressive Retinal Photoreceptor Degeneration. J Nanomater Mol Nanotechnol 2:4. doi:10.4172/2324-8777.1000116

Abstract

Neuroprotective Effect of Photoactive Quantum Dots in Progressive Retinal Photoreceptor Degeneration

Background:

To determine the effect of intraocularly administered photoactive quantum dots in a rodent model of progressive photoreceptor degeneration.

Methods: The Royal College of Surgeons (RCS) rat model of progressive photoreceptor degeneration was used for this study. Twenty eyes of ten animals were divided into four groups: active implant, inactive implant, sham surgery, and control group. The active and inactive implant group received a single intravitreal injection of photoactive quantum dots conjugated with biotin. The sham surgery group received an intravitreal injection of balanced saline solution, and the control group underwent no surgical procedure. All procedures were done at week six of life and weekly electroretinograms (ERG) recorded for the following six weeks.

Results: Both the control and sham surgery groups demonstrated a progressive decline in the amplitude of the ERG recordings over the six weeks post-procedure. In contrast, the eyes receiving intravitreal photoactive quantum dots demonstrated transient, but statistically significant increases in retinal electrical activity postinjection.

Conclusions: The observed increase in retinal electrical activity following intravitreal injection of photoactive quantum dots in the RCS rat model suggests a potential therapeutic role for this technology in progressive retinal degenerations.

Keywords:

Track Your Manuscript

Share This Page

Associations